250 related articles for article (PubMed ID: 12853231)
1. Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?
Fiala KH; Whetteckey J; Manyam BV
Parkinsonism Relat Disord; 2003 Aug; 9(6):321-7. PubMed ID: 12853231
[TBL] [Abstract][Full Text] [Related]
2. [Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma].
Kleinhans M; Schmid-Grendelmeier P; Burg G
Hautarzt; 1996 Jun; 47(6):432-7. PubMed ID: 8767657
[TBL] [Abstract][Full Text] [Related]
3. Levodopa therapy and the risk of malignant melanoma.
Siple JF; Schneider DC; Wanlass WA; Rosenblatt BK
Ann Pharmacother; 2000 Mar; 34(3):382-5. PubMed ID: 10917387
[TBL] [Abstract][Full Text] [Related]
4. Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature.
Kochar AS
Am J Med; 1985 Jul; 79(1):119-21. PubMed ID: 4014296
[TBL] [Abstract][Full Text] [Related]
5. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
Zanetti R; Loria D; Rosso S
Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266
[TBL] [Abstract][Full Text] [Related]
6. Safety of long-term levodopa therapy in malignant melanoma.
Woofter MJ; Manyam BV
Clin Neuropharmacol; 1994 Aug; 17(4):315-9. PubMed ID: 9316678
[TBL] [Abstract][Full Text] [Related]
7. Malignant melanoma in early Parkinson's disease: the DATATOP trial.
Constantinescu R; Romer M; Kieburtz K;
Mov Disord; 2007 Apr; 22(5):720-2. PubMed ID: 17373726
[TBL] [Abstract][Full Text] [Related]
8. Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.
Pfützner W; Przybilla B
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):332-6. PubMed ID: 9270541
[TBL] [Abstract][Full Text] [Related]
9. Treatment with levodopa and risk for malignant melanoma.
Olsen JH; Tangerud K; Wermuth L; Frederiksen K; Friis S
Mov Disord; 2007 Jul; 22(9):1252-7. PubMed ID: 17534943
[TBL] [Abstract][Full Text] [Related]
10. [Melanoma while using levodopa due to Parkinson's disease--causal association unlikely].
Wobbes T; Bonenkamp JJ
Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1286-8. PubMed ID: 12138675
[TBL] [Abstract][Full Text] [Related]
11. Levodopa and melanoma: three cases and review of literature.
Rampen FH
J Neurol Neurosurg Psychiatry; 1985 Jun; 48(6):585-8. PubMed ID: 4009196
[TBL] [Abstract][Full Text] [Related]
12. Melanoma and levodopa.
Rampen F
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):782-4. PubMed ID: 9591833
[No Abstract] [Full Text] [Related]
13. Parkinson's disease, melanoma, and levodopa.
Fermaglich J; Delaney P
J Neurol; 1977 Jun; 215(3):221-4. PubMed ID: 69691
[No Abstract] [Full Text] [Related]
14. Levodopa, melanoma, and Parkinson's disease.
Weiner WJ; Singer C; Sanchez-Ramos JR; Goldenberg JN
Neurology; 1993 Apr; 43(4):674-7. PubMed ID: 8469320
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease, levodopa-use and the risk of melanoma.
Vermeij JD; Winogrodzka A; Trip J; Weber WE
Parkinsonism Relat Disord; 2009 Sep; 15(8):551-3. PubMed ID: 19501540
[TBL] [Abstract][Full Text] [Related]
16. Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach.
Bougea A; Spantideas N; Katoulis A; Stefanis L
Acta Neurol Belg; 2019 Sep; 119(3):325-336. PubMed ID: 31338806
[TBL] [Abstract][Full Text] [Related]
17. Levodopa therapy and malignant melanoma.
Sober AJ; Wick MM
JAMA; 1978 Aug; 240(6):554-5. PubMed ID: 671667
[TBL] [Abstract][Full Text] [Related]
18. Levodopa and the risk of melanoma.
Zanetti R; Rosso S
Lancet; 2007 Jan; 369(9558):257-8. PubMed ID: 17258651
[No Abstract] [Full Text] [Related]
19. Uveal malignant melanoma and levodopa therapy in Parkinson's disease.
Van Rens GH; De Jong PT; Demols EE; Brihaye-Van Geertruyden MF
Ophthalmology; 1982 Dec; 89(12):1464-6. PubMed ID: 7162789
[No Abstract] [Full Text] [Related]
20. Current controversies: levodopa in the treatment of Parkinson's disease.
Sharma JC; Vassallo M; Ross IN
Mov Disord; 2005 May; 20(5):642-3; author reply 643-4. PubMed ID: 15732129
[No Abstract] [Full Text] [Related]
[Next] [New Search]